Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Bio-Path Stock Performance Shares of Bio-Path stock opened at $0.77 on Friday. Bio-Path has a twelve month low of $0.61 and a twelve month high of $12.37. The business […]
More Stories
Trump Unveils New Health Care Affordability Plan
By Lawrence Wilson President Donald Trump on Jan. 15 released his administration’s new health care affordability plan, which aims to...
US, Denmark, Greenland to Form Working Group to Find Agreement on Island’s Future
By Ryan Morgam and Emel Akan WASHINGTON—Following a White House meeting on Jan. 14, the foreign ministers of Denmark and...
SEO for Manufacturing Companies: Strategies to Generate High-Quality Leads
SEO has become the biggest part of life in this competitive world. The efficient use of SEO can be done...
The USA “Needs Greenland for the Purpose of National Security”: Trump Remains Adamant
On 14 January, US President Donald Trump declared that “anything less than having Greenland in the hands of the United...
Trump Threatens to Invoke Insurrection Act to End Anti-ICE Protests in Minnesota
By Sam Dorman President Donald Trump has threatened to use the Insurrection Act in Minnesota following an attack on an...
How ICE Was Targeted in Minneapolis for Weeks Before Fatal Shooting
By Jacki Thrapp MINNEAPOLIS—Activists in Minneapolis are continuing to organize efforts to impede immigration enforcement as the Trump administration surges...